22-Oct-2026 - Zacks Investment Research LH vs. DHR: Which stock is the better value option? Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors? We'll need to ...
22-Oct-2026 - Seeking Alpha Danaher Q3 Recap: Decent Results, Still A Hold Danaher stock is rated Hold after solid Q3 earnings, but premium valuation and China pricing pressure limit upside. Read more ...
22-Oct-2026 - Yahoo Finance Danaher (DHR) Stock Fair Value Edges Higher After Analysts Lift Targets Danaher is back in focus as analysts edge price targets into the US$240 to US$255 range, with some models now centering around fair value of about US$244.14. This shift reflects recent research that ...
21-Oct-2026 - Yahoo Finance Danaher Jumps 4% on Q3 Beat: “Improving Trends” Across Its End Markets Danaher (DHR:NYSE) shares were up about 4% on Wednesday (trading at about $233) after the life sciences company beat third-quarter profit estimates and raised its full-year earnings guide. The stock ...
22-Oct-2026 - Zacks Investment Research LH vs. DHR: Which stock is the better value option? Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors? We'll need to ...
22-Oct-2026 - Seeking Alpha Danaher Q3 Recap: Decent Results, Still A Hold Danaher stock is rated Hold after solid Q3 earnings, but premium valuation and China pricing pressure limit upside. Read more ...
22-Oct-2026 - Yahoo Finance Danaher (DHR) Stock Fair Value Edges Higher After Analysts Lift Targets Danaher is back in focus as analysts edge price targets into the US$240 to US$255 range, with some models now centering around fair value of about US$244.14. This shift reflects recent research that ...
21-Oct-2026 - Yahoo Finance Danaher Jumps 4% on Q3 Beat: “Improving Trends” Across Its End Markets Danaher (DHR:NYSE) shares were up about 4% on Wednesday (trading at about $233) after the life sciences company beat third-quarter profit estimates and raised its full-year earnings guide. The stock ...
